Shilpa Medicare Ltd (SHILPAMED)

Shilpa Medicare Shares Hit 52-Week High on GMP Certification and Product Launch - 18 Apr, 2024

Shilpa Medicare Ltd's Unit-4 facility in Jadcherla, Telangana, received GMP certification from AGES, Austria. The company also announced the launch of PEMRYDI RTU by its marketing partner Amneal Pharmaceuticals. Shilpa Medicare's share price touched a 52-week high of ₹558 after these announcements.

Shilpa Medicare Receives EU GMP Certificate for Telangana Facility - 17 Apr, 2024

Shilpa Medicare's Unit 4 facility in Jadcherla, Telangana has received the EU good manufacturing practice (GMP) certificate, allowing it to continue supplying medicines to various countries in the European Union. The company reported a consolidated net profit of Rs 4.58 crore in Q3 FY24 and its stock rallied by 6.14%.

Shilpa Medicare Receives GMP Certification for Unit 4 Facility - 16 Apr, 2024

Shilpa Medicare's unit 4 facility in Telangana has received the Good Manufacturing Practice certification from AGES, Austria. The certification will enable continued supply of medicines to various countries in the European Union.

Shilpa Medicare Raises Rs 500 Crore Through QIP Issue - 15 Apr, 2024

Shilpa Medicare has raised Rs 500 crore through a qualified institutional placement (QIP) issue, with participation from funds managed by Sunil Singhania and Madhusudan Kela. ICICI Prudential and Bandhan Mutual Fund also participated in the QIP issue, which was priced at Rs 455 per share.

Shilpa Medicare Raises Rs 500 Crore Through QIP - 13 Apr, 2024

Shilpa Medicare has successfully raised Rs 500 crore through a Qualified Institutional Placement (QIP) by allotting 1.09 crore equity shares to eligible institutional buyers at an issue price of Rs 455 per share.

Shilpa Medicare Shares Surge 27% in a Month - 12 Apr, 2024

Shilpa Medicare shares have gained 27% in the last month and 101% in the last year. However, its P/S ratio of 4x is higher than almost half the companies in India's Pharmaceuticals industry, and revenue growth has been inconsistent recently. Elevated P/S may not be rational, and there is considerable risk of share price declining if recent medium-term revenue trends continue.

Shilpa Medicare Launches QIP at Floor Price of Rs 477.33 Per Share - 09 Apr, 2024

Pharmaceutical company Shilpa Medicare has launched a Qualified Institutional Placement (QIP) to raise funds at a floor price of Rs 477.33 per share. The board authorized the QIP to raise up to Rs 500 crore and may offer a discount of up to 5%. The stock surged by 4.3%, reaching a 52-week high. Analysts predict positive momentum for the stock.

Shilpa Medicare Board Approves QIP - 08 Apr, 2024

Shilpa Medicare Ltd.'s board has approved a qualified institutional placement (QIP) at a floor price of Rs 477.33 per equity share. The Relevant Date for the purpose of the Issue is April 8, 2024.